• Explore /
  • Poster
  • / Randomized phase II trial of gemcitabine plus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805).

Randomized phase II trial of gemcitabine plus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805).

Abstract Poster

Authors

Chigusa Morizane

Chigusa Morizane

National Cancer Center Hospital, Tokyo, Japan

Chigusa Morizane , Takuji Okusaka , Junki Mizusawa , Atsuo Takashima , Makoto Ueno , Masafumi Ikeda , Yasuo Hamamoto , Hiroshi Ishii , Narikazu Boku , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000001685

Citation

J Clin Oncol 30, 2012 (suppl 4; abstr 255)

DOI

10.1200/jco.2012.30.4_suppl.255

Abstract #

255

Poster Bd #

C19

Abstract Disclosures

Similar Posters

First Author: Makoto Ueno

First Author: John Ebben

First Author: Richard D. Kim

First Author: Arndt Vogel